ORIC Pharmaceuticals, Inc.
ORIC Pharmaceuticals, Inc.（ORIC）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · ORIC · 截至 2026年6月8日
活动摘要
买入笔数
2
P-Purchase only
卖出笔数
21
近12个月
买卖比
0.10
Buy/Sell (by trades)
整体情绪
ORIC Pharmaceuticals, Inc.内部人在过去近12个月主要在卖出股份，卖出行为通常由预设的Rule 10b5-1计划驱动，不一定代表对公司的负面看法。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月8日
ORIC 季度内部人买卖趋势
ORIC 内幕交易卖出 · ORIC 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 8, 2026
活跃内部人
近12个月交易最活跃 · ORIC CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
ORIC 高管卖出股份 · ORIC 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Feb 24, 2026 | Piscitelli Dominic CFO | Option | 52,000 | $227K | Form 4 |
| Feb 24, 2026 | Piscitelli Dominic CFO | Sale | 52,000 | $703K | Form 4 |
| Jan 16, 2026 | Heyman Richard A. Director | Sale | 3,200 | $38K | Form 4 |
| Jan 16, 2026 | Heyman Richard A. Director | Sale | 3,500 | $42K | Form 4 |
| Dec 15, 2025 | Multani Pratik S Chief Medical Officer | Option | 29,333 | — | Form 4 |
| Dec 16, 2025 | Multani Pratik S Chief Medical Officer | Sale | 10,720 | $97K | Form 4 |
| Dec 15, 2025 | Piscitelli Dominic CFO | Option | 29,333 | — | Form 4 |
| Dec 16, 2025 | Piscitelli Dominic CFO | Sale | 10,720 | $97K | Form 4 |
| Dec 15, 2025 | Chacko Jacob PRESIDENT AND CEO · Director | Option | 83,666 | — | Form 4 |
| Dec 16, 2025 | Chacko Jacob PRESIDENT AND CEO · Director | Sale | 33,374 | $302K | Form 4 |
| Dec 8, 2025 | Kunkel Lori Anne Director | Option | 10,000 | $79K | Form 4 |
| Dec 4, 2025 | Kunkel Lori Anne Director | Option | 5,534 | $21K | Form 4 |
| Oct 6, 2025 | Piscitelli Dominic CFO | Option | 11,000 | $48K | Form 4 |
| Oct 6, 2025 | Piscitelli Dominic CFO | Sale | 11,000 | $160K | Form 4 |
| Oct 6, 2025 | Chacko Jacob PRESIDENT AND CEO · Director | Sale | 37,461 | $462K | Form 4 |
| Oct 3, 2025 | Heyman Richard A. Director | Option | 1,447 | $5K | Form 4 |
| Oct 3, 2025 | Heyman Richard A. Director | Option | 31,353 | $50K | Form 4 |
| Sep 30, 2025 | Chacko Jacob PRESIDENT AND CEO · Director | Sale | 34,538 | $415K | Form 4 |
| Oct 1, 2025 | Chacko Jacob PRESIDENT AND CEO · Director | Sale | 53,001 | $639K | Form 4 |
| Sep 22, 2025 | Chacko Jacob PRESIDENT AND CEO · Director | Sale | 125,000 | $1.35M⚡ | Form 4 |
| Jul 1, 2025 | Piscitelli Dominic CFO | Sale | 20,000 | $201K | Form 4 |
| Jun 23, 2025 | Piscitelli Dominic CFO | Sale | 584 | $6K | Form 4 |
| Jun 23, 2025 | Piscitelli Dominic CFO | Sale | 450 | $5K | Form 4 |
| Jun 24, 2025 | Piscitelli Dominic CFO | Sale | 32,466 | $341K | Form 4 |
| Jun 23, 2025 | You Angie Director | Purchase | 1,403 | $13K | Form 4 |
Chacko Jacob
PRESIDENT AND CEO · Director
日期
Sep 22
股数
125,000
均价
$10.80
总金额
$1.35M ⚡
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 ORIC 内幕交易
ORIC 内幕交易
ORIC Pharmaceuticals, Inc.（ORIC）内幕交易数据来源于公司内部人（包括Piscitelli Dominic (CFO), Chacko Jacob (PRESIDENT AND CEO · Director), Heyman Richard A. (Director)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。ORIC内部人近期主要在卖出，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看ORIC Pharmaceuticals, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
ORIC 内幕交易 · 5个问题ORIC Pharmaceuticals, Inc.（ORIC）的内部人包括高管和董事，如Piscitelli Dominic (CFO), Chacko Jacob (PRESIDENT AND CEO · Director), Heyman Richard A. (Director)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 8, 2026